Related Experiment Video
Updated: Jun 12, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
[Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences]
L Roznovský1, I Orságová, L Petrousová
1Klinika infekcního lékarství, Fakultní nemocnice Ostrava. ludek.roznovsky@fnspo.cz
Abstract:
Retreatment with peginterferon plus ribavirin was initiated in 26 patients with hepatitis C virus genotype 1b infection (17 relapsers after the first course of therapy, 9 non-responders). So far, retreatment has been completed in 19 patients, one patient achieved a sustained virologic response, and 3 patients were relapsers. Therapy was discontinued in 14 patients (9 non-responders) because of a lack of a treatment response, and in 1 patient due to adverse effects. Retreatment is a new chance for patients with chronic hepatitis C infection. However successful outcome is rare especially in non-responders.
Related Concept Videos
Hepatitis
Chronic Pancreatitis II: Collaborative Care
Assessment:
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Treatment Resistent Cancers
Retrovirus Life Cycles
